LungLife AI Company
LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.
Estimated Revenue:
$1M to $10M
Funding Status:
IPO
Industry:
Medical BioTech
Investors Number:
3
Last Funding Date:
2015-06-17
Technology:
['BioTech & HealthTech']
Founded Date:
2006-01-01
Headquarters:
Thousand Oaks, California, United States
Total Funding:
45825885
Last Funding Type:
Series B
Employee Number:
1-10